FDA reconsiders COVID-19 booster approvals, with Makary emphasizing the need for “good data”
(NaturalNews) The FDA is reconsidering its approach to COVID-19 vaccine approvals for the upcoming season, citing insufficient data on booster effectiveness...

![]() | (NaturalNews) The FDA is reconsidering its approach to COVID-19 vaccine approvals for the upcoming season, citing insufficient data on booster effectiveness... |